HomePMVP • NASDAQ
add
PMV Pharmaceuticals Inc
Previous close
$0.88
Year range
$0.81 - $1.83
Market cap
45.47M USD
Avg Volume
245.98K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 21.56M | 22.38% |
Net income | -17.44M | -14.18% |
Net profit margin | — | — |
Earnings per share | -0.34 | -13.33% |
EBITDA | -21.53M | -24.73% |
Effective tax rate | 11.19% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 160.39M | -18.97% |
Total assets | 170.61M | -27.98% |
Total liabilities | 10.50M | -56.61% |
Total equity | 160.11M | — |
Shares outstanding | 51.95M | — |
Price to book | 0.28 | — |
Return on assets | -29.79% | — |
Return on capital | -31.85% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -17.44M | -14.18% |
Cash from operations | -18.27M | -12.86% |
Cash from investing | 28.71M | 9.74% |
Cash from financing | 10.00K | — |
Net change in cash | 10.46M | 5.20% |
Free cash flow | -13.47M | -24.65% |
About
Founded
2013
Website
Employees
47
